| Aloysia Schwabe, MD | |
|
6621 Fannin St, Houston, TX 77030-2303 | |
| (832) 826-6105 | |
| (832) 825-5242 |
| Full Name | Aloysia Schwabe |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 29 Years |
| Location | 6621 Fannin St, Houston, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063592491 | NPI | - | NPPES |
| 102840903 | Medicaid | TX | |
| 250012248 | Medicaid | TX | |
| 102840901 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P0010X | Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine | K8478 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Childrens Physician Group | 4385722081 | 357 |
News Archive
Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. has initiated the treatment of the first patient in the second of two pivotal studies from the OBI-1's Accur8 clinical trial program.
C.S. Lewis, the famous author and Oxford academic, once proclaimed "You can't get a cup of tea big enough or a book long enough to suit me." We sip it with toast in the morning, enjoy it with sweets and biscuits in the afternoon, and relax with it at the end of the day.
Scientists have just discovered how the engine that powers cancer-killing cells functions. Crucially, their research also highlights how that engine is fuelled and that cholesterol-like molecules, called oxysterols, act as a "cut-off" switch making it hard for our 'Natural Killer' cells to win the war against cancer.
Preschool children preferred the taste of foods and drinks in McDonald's packaging to the same foods and drinks in unbranded packaging, according to a report in the August issue of Archives of Pediatrics & Adolescent Medicine.
Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.
› Verified 1 days ago
| Entity Name | Texas Childrens Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861675506 PECOS PAC ID: 4385722081 Enrollment ID: O20080422000209 |
News Archive
Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. has initiated the treatment of the first patient in the second of two pivotal studies from the OBI-1's Accur8 clinical trial program.
C.S. Lewis, the famous author and Oxford academic, once proclaimed "You can't get a cup of tea big enough or a book long enough to suit me." We sip it with toast in the morning, enjoy it with sweets and biscuits in the afternoon, and relax with it at the end of the day.
Scientists have just discovered how the engine that powers cancer-killing cells functions. Crucially, their research also highlights how that engine is fuelled and that cholesterol-like molecules, called oxysterols, act as a "cut-off" switch making it hard for our 'Natural Killer' cells to win the war against cancer.
Preschool children preferred the taste of foods and drinks in McDonald's packaging to the same foods and drinks in unbranded packaging, according to a report in the August issue of Archives of Pediatrics & Adolescent Medicine.
Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aloysia Schwabe, MD 6621 Fannin St, Houston, TX 77030-2303 Ph: (832) 826-6105 | Aloysia Schwabe, MD 6621 Fannin St, Houston, TX 77030-2303 Ph: (832) 826-6105 |
News Archive
Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. has initiated the treatment of the first patient in the second of two pivotal studies from the OBI-1's Accur8 clinical trial program.
C.S. Lewis, the famous author and Oxford academic, once proclaimed "You can't get a cup of tea big enough or a book long enough to suit me." We sip it with toast in the morning, enjoy it with sweets and biscuits in the afternoon, and relax with it at the end of the day.
Scientists have just discovered how the engine that powers cancer-killing cells functions. Crucially, their research also highlights how that engine is fuelled and that cholesterol-like molecules, called oxysterols, act as a "cut-off" switch making it hard for our 'Natural Killer' cells to win the war against cancer.
Preschool children preferred the taste of foods and drinks in McDonald's packaging to the same foods and drinks in unbranded packaging, according to a report in the August issue of Archives of Pediatrics & Adolescent Medicine.
Relapsing-Remitting Multiple Sclerosis (RRMS) patients have been anticipating the availability of new oral therapies being developed to treat their specific condition. Among the string of oral therapies entering the market is Novartis' Gilenya, which recently became available for use following receipt of FDA approval in late September. One-third of MS patients are aware the new oral agents are under development and there is substantial interest within this group to seek further information through physicians and other sources, according to new research by GfK HealthCare.
› Verified 1 days ago
Dr. Suzanne Marie Manzi, M.D., FAAPMR Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4126 Southwest Fwy Ste 1700, Houston, TX 77027 Phone: 346-217-1111 Fax: 346-571-2189 | |
Miguel Ernesto Velez, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2727 W Holcombe Blvd, Houston, TX 77025 Phone: 713-442-0000 | |
Sara Goel, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 7700 Main St Ste 400, Houston, TX 77030 Phone: 346-230-4070 Fax: 281-605-6804 | |
Dr. Michael Krebs, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 5202 Redstart St, Houston, TX 77035 Phone: 281-531-5200 Fax: 281-531-5430 | |
Dr. Tova Liana Alladice, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8200 Wednesbury Ln, Suite 360, Houston, TX 77074 Phone: 713-484-6200 Fax: 713-773-0905 | |
Susan Victoria Kattula Gammon, OTR/L Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6621 Fannin St., Houston, TX 77030 Phone: 832-826-6121 Fax: 630-792-1801 | |
Savitha Bonthala, D.O., M.P.H. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1300 Binz St Fl 3, Houston, TX 77004 Phone: 713-285-1000 |